Clinical Trials Logo
  1. Home
  2. Asthma, Bronchial
  3. NCT03839433

The Mannitol-Asthma-Ciclesonide-Study — MACS  

Asthma, Bronchial Clinical Trial

Official title:
Ciclesonide for the Treatment of Airway Hyperresponsiveness: The Mannitol-Asthma-Ciclesonide-Study

Clinical Trial Summary

Response of a 4 weeks treatment with daily once 320 µg ciclesonide on airway hyperresponsiveness assessed with mannitol.

Hypothesis: Treatment with inhaled ciclesonide reduces airway hyper-responsiveness in 80% of hyper-responsive patients compared to 20% only in the placebo group and the group without airway hyper-responsiveness.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03839433
Study type Interventional
Source Cantonal Hosptal, Baselland
Contact
Status Completed
Phase Phase 4
Start date June 2007
Completion date August 2008
View Details
See also
  Status Clinical Trial Phase
Completed NCT00825903 - The Effects of Exercise on Physiological and Psychological Parameters in an Asthmatic Population N/A
Completed NCT00734318 - Study of FlutiForm® Versus Fluticasone Plus Formoterol in Adult Subjects With Severe Asthma Phase 3
Terminated NCT00385593 - Symbicort Single Inhaler Therapy vs Conventional Best Practice for the Treatment of Persistent Asthma in Adults Phase 3
Completed NCT00213252 - Use of Montelukast to Treat Children With Mild to Moderate Acute Asthma Phase 2
Completed NCT00092092 - Study of Montelukast and Its Effect on Lower Leg Growth in Children With Asthma (MK-0476-254) Phase 4
Completed NCT00489346 - A Study to Evaluate MK0476 and Fluticasone to Control Asthma in Patients With Mild Persistent Asthma (0476-910) Phase 3
Withdrawn NCT03989635 - Mechanistic Study of Anti-inflammatory Effects of Fevipiprant in Patients With Eosinophilic Asthma. Phase 2
Withdrawn NCT00540839 - A Study of Montelukast (MK-0476) Compared With Fluticasone in Pediatric Participants With Chronic Asthma (MK-0476-303) Phase 3
Recruiting NCT06299306 - REACT - REAl Care for AsThma - A Disease Study to Identify Patients With Severe Uncontrolled Asthma
Recruiting NCT00312312 - Allergy Towards Grass and Bronchial Inflammation - Related to Immunotherapy and Exhaled Nitrogen Oxide N/A
Completed NCT00092885 - An Approved Drug to Study a New Indication for Seasonal Allergic Rhinitis in Patients With Asthma (0476-269) Phase 3
Not yet recruiting NCT06422078 - A Non-interventional, Prospective Study With Benralizumab
Completed NCT02805907 - Efficacy of Calcifediol Supplementation in Asthma Control in Asthmatic Patients With Vitamin D Deficiency (ACViD) Phase 4
Not yet recruiting NCT00644462 - Wheeze Detection in Adults During Dynamic Bronchial Situations Measured by PulmoTrack® 2010 With WIM-PC™ Technologies Recording N/A
Completed NCT00640120 - Wheeze Detection in Children During Dynamic Bronchial Situations Measured by WIM-PC™ Recording N/A
Recruiting NCT05937334 - The Cohort Study for Asthma in China
Completed NCT03034447 - Sleep Apnea in Asthmatic Children and Teenagers N/A
Completed NCT05270278 - Characteristics of Type 2- High Inflammatory Endotype of Asthma Using New Biomarkers From Peripheral Blood and Exhaled Air and Its Effect on the Outcome of Therapy
Withdrawn NCT00830427 - A Study To Examine The Safety And Efficacy Of PF-00610355 In Moderately Asthmatic Subjects Phase 2
Completed NCT00092105 - Study of MK0476 (Montelukast Sodium) and Effects on Asthma and Nasal Symptoms Upon Exposure to Cats (0476-256) Phase 3